Redwood Wealth Management Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$277K Hold
1,815
0.12% 139
2025
Q4
$250K Sell
1,815
-98
-5% -$12.8K 0.1% 156
2025
Q3
$245K Sell
1,913
-150
-7% -$18.3K 0.1% 155
2025
Q2
$250K Sell
2,063
-80
-4% -$9.02K 0.11% 156
2025
Q1
$239K Sell
2,143
-75
-3% -$7.98K 0.12% 143
2024
Q4
$216K Sell
2,218
-130
-6% -$13.9K 0.11% 152
2024
Q3
$270K Hold
2,348
0.13% 135
2024
Q2
$250K Sell
2,348
-10
-0.4% -$1K 0.19% 102
2024
Q1
$228K Sell
2,358
-10
-0.4% -$1.02K 0.24% 106
2023
Q4
$239K Hold
2,368
0.27% 103
2023
Q3
$241K Sell
2,368
-330
-12% -$33.5K 0.28% 101
2023
Q2
$272K Sell
2,698
-55
-2% -$5.5K 0.3% 95
2023
Q1
$253K Sell
2,753
-200
-7% -$17.5K 0.29% 106
2022
Q4
$268K Buy
+2,953
New +$249K 0.33% 87

Other funds holding NVS

Redwood Wealth Management Group's NVS Position: Q1 2026 in Review

Redwood Wealth Management Group held its Novartis (NVS) position steady in Q1 2026 at 1,815 shares worth $277K. The position accounts for 0.12% of the portfolio, ranked #139.

Redwood Wealth Management Group first reported a position in NVS in Q4 2022 and has held it in 14 quarters since. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Redwood Wealth Management Group held 1,815 shares of Novartis worth $277K as of Q1 2026.
  • Redwood Wealth Management Group left its Novartis share count unchanged in Q1 2026.
  • Novartis made up 0.12% of Redwood Wealth Management Group's portfolio in Q1 2026, its #139 holding.
  • Redwood Wealth Management Group first reported a position in Novartis in Q4 2022 and has held it in 14 quarters since.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Redwood Wealth Management Group's 13F filing for Q1 2026, filed 24 Apr 2026.